ACUTE MYELOID LEUKEMIA POST CYTOTOXIC THERAPY
Clinical trials for ACUTE MYELOID LEUKEMIA POST CYTOTOXIC THERAPY explained in plain language.
Never miss a new study
Get alerted when new ACUTE MYELOID LEUKEMIA POST CYTOTOXIC THERAPY trials appear
Sign up with your email to follow new studies for ACUTE MYELOID LEUKEMIA POST CYTOTOXIC THERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New attack on hidden cancer cells could boost leukemia cure rates
Disease control Not yet recruitingThis study is for adults with a type of blood cancer called acute myeloid leukemia (AML) who have a small amount of leftover cancer after initial treatment. The goal is to test if adding newer drugs to a standard chemotherapy is better at wiping out these hidden cancer cells befo…
Matched conditions: ACUTE MYELOID LEUKEMIA POST CYTOTOXIC THERAPY
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC
-
New oral drug combo tested to keep Kids' leukemia at bay after transplant
Disease control Not yet recruitingThis early-stage study aims to find a safe dose and understand the side effects of an oral drug combination called ASTX727, given with a white blood cell booster (filgrastim), in children with high-risk acute myeloid leukemia (AML). The treatment is given as 'maintenance therapy'…
Matched conditions: ACUTE MYELOID LEUKEMIA POST CYTOTOXIC THERAPY
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC